The GLP1R gene encodes the glucagon-like peptide-1 receptor, a protein that plays a crucial role in glucose homeostasis and insulin secretion regulation. As a G protein-coupled receptor (GPCR), it primarily binds to the incretin hormone GLP-1, secreted by intestinal L cells after nutrient intake. Activation of GLP1R triggers an intracellular signaling cascade, particularly through the cAMP-PKA pathway, promoting glucose-dependent insulin secretion from pancreatic β-cells. This receptor also inhibits glucagon secretion, slows gastric emptying, and enhances satiety, making it a significant therapeutic target for type 2 diabetes and obesity.
The human NTSR2 stable cell line-CHO-K1 is a cell model specifically designed for high-throughput screening and pharmacological studies of the neurotensin receptor type 2 (NTSR2). Derived from Chinese hamster ovary (CHO-K1) cells, this cell line stably expresses the human NTSR2 gene, ensuring continuous receptor availability for ligand binding assays, signal transduction analysis, and drug discovery. Neurotensin receptors, including NTSR2, are GPCRs involved in various physiological processes such as pain modulation, dopamine regulation, and cancer progression. The CHO-K1 host cell line offers advantages such as robust growth, ease of expansion, and low levels of endogenous GPCR expression, minimizing background interference. Researchers utilize this stable cell line to study receptor-ligand interactions, screen potential therapeutic drugs for neurological disorders, and investigate the role of NTSR2 in cellular pathways, providing a reliable platform for advancing neuropharmacology and oncology research.
The incidence of diabetic cognitive impairment is increasing year by year and is gradually becoming a research hotspot. Studies have shown that glucagon-like peptide-1 receptor (GLP-1R) agonists can improve cognitive impairment in diabetic patients. Here, researchers explored whether small molecule GLP-1R agonists derived from traditional Chinese medicine could improve diabetic cognitive impairment. The study found that mollugin can bind to GLP-1R, promote Ca2+ influx in β-TC-6 cells, and increase insulin secretion and cAMP content. Mollugin also enhanced the viability of PC12 cells, reduced apoptosis, and lowered reactive oxygen species (ROS) levels in high glucose (HG)/hydrogen peroxide (H2O2)-damaged PC12 cells. Furthermore, mollugin shortened the escape latency in type 2 diabetic mice, improved neuronal damage, and reduced the expression of Pik3ca, Akt1, and Mapk1 mRNA in brain cortical tissue. These results suggest that mollugin may improve cognitive impairment in type 2 diabetic mice by activating the GLP-1R/cAMP/PKA signaling pathway.
Previous studies suggested that small molecules might have an affinity for GLP-1R, but it was not yet determined whether they were agonists or antagonists. To further confirm whether these small molecules could activate GLP-1R, researchers used calcium imaging technology to detect the effect of these small molecules on intracellular Ca2+ concentration in GLP1R Stable Cell Line - HEK293 (GLP-1R-HEK293) cells. Ca2+, as a second messenger, can reflect the binding of extracellular signals to cell surface receptors. The study showed that nobiletin, isosinensetin and mollugin can significantly promote calcium influx in GLP-1R-HEK293 cells (Figure 1A–G). To further determine the effect of these small molecules on GLP-1R, researchers measured their effect on insulin secretion in β cells. As shown in Figure 1H, these small molecules in 10 μM could promote insulin secretion by β cells in the presence of 1.38 mM glucose, as the positive drug liraglutide did, and the stimulatory effect of mollugin was the most significant. These preliminary results suggest that mollugin, isosinensetin and nobiletin may be GLP-1R agonists.
Figure 1. Calcium imaging of small molecules on GLP-1R-HEK293 cells. (Wang Z, et al., 2023)
Customer Reviews
Work well
We adopted the Human GLP1R Stable Cell Line - HEK293 into our GPCR screening workflow and it’s been consistently reliable. Post-thaw recovery is smooth, signal windows in cAMP assays are robust with low background, and expression remains stable across passages.
Robust GLP-1R Activation in HEK293
Creative Biogene’s Human GLP-1R Stable Cell Line in HEK293 has delivered outstanding cAMP response curves with minimal background noise. The high expression level and rapid turnaround from thaw to assay made our drug screening pipeline far more efficient.
Write a Review